InvestorsHub Logo
Followers 10
Posts 1111
Boards Moderated 0
Alias Born 04/07/2013

Re: zumantu post# 79843

Saturday, 05/07/2016 1:25:54 PM

Saturday, May 07, 2016 1:25:54 PM

Post# of 425625
Zum: It's been along time, hope you're well. I was not at
all surprised by the financial statement showing that
Management padded their pockets to the tune of $20M.
When I started talking about how the CEO et al were
totally incompetent and only staying on to collect a
paycheck, some of the Board were irate. It's to late
in the game to do anything now. That said, the new
Cures legislation includes allowing Co's to market
their drugs off label with the same requisites that
apply to AMRN. Management spent a fortune and won nothing,
other than about a 6 month head start. You all still
have not obtained the NCE. What has management accomplished ?
Absolutely nothing except to keep their paychecks coming. Most
decent Biotechs when cash strapped as AMRN is cut their
salaries, and don't reward themselves with stock options
and bonuses. You all are so close to the situation that
you can't see the forest for the trees. When a CFO leaves
as AMRN's just did , it's usually because he sees the ominous
signs of failure. One important fact that I kept telling you
about was the major issue of not being fully enrolled. That
affects the Hazard Ratio as well as Power of R-IT. It has
most likely turned R-IT into a binary event. I am still rooting
for Vascepa, but have the same strong doubts about the company's
survival. I hate to see all the longs lose at the end of the day,
after all you've been through.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News